ETON · NASDAQ · Drug Manufacturers - Specialty & Generic

Eton Pharmaceuticals

Develops and commercializes rare-disease therapies through product launches and rights agreements.

$59.78
After-hours close−0.01 (−0.02%)
At close$59.79(−4.60%)
DateEstimateReportedSurprise
Nov 2026$0.34
Aug 2026$0.19$0.43+126.6%
May 2026$0.10$0.05−50.0%
Mar 2026$0.12$0.05−58.3%
Nov 2025$0.16−$0.07−143.8%

The latest year is open to everyone — the 33 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Dec 2018
Jun 2018
Mar 2018
Dec 2017
Sep 2017
Jun 2017
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 5, 2026$0.34$42.0M
Aug 13, 2026$0.19$0.43+126.6%$27.1M$37.6M+38.7%
May 14, 2026$0.10$0.05−50.0%$22.3M$24.3M+8.8%
Mar 19, 2026$0.12$0.05−58.3%$20.0M$21.3M+6.5%
Nov 6, 2025$0.16−$0.07−143.8%$20.5M$22.5M+9.7%

The latest year is open to everyone — the 33 quarters behind it read with an account.

Sign in
Aug 7, 2025
May 13, 2025
Mar 18, 2025
Nov 12, 2024
Aug 8, 2024
May 9, 2024
Mar 14, 2024
Nov 9, 2023
Aug 10, 2023
May 11, 2023
Mar 16, 2023
Nov 10, 2022
Aug 11, 2022
May 12, 2022
Mar 16, 2022
Nov 15, 2021
Aug 16, 2021
May 13, 2021
Mar 16, 2021
Nov 12, 2020
Aug 12, 2020
May 14, 2020
Mar 5, 2020
Nov 14, 2019
Aug 6, 2019
May 7, 2019
Mar 25, 2019
Dec 20, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Sep 30, 2017
Jun 30, 2017